A chicken egg at Neion Bio, a biotech start-up, receiving a microinjection. The company aims to to turn chicken eggs into ...
Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials. The company ​tested the drug, povorcitinib, in patients with ‌moderate to ...
Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...
LLY's obesity drugs fuel explosive growth, while ABBV depends on Skyrizi and Rinvoq. Let's see which drugmaker has the ...
Two posters demonstrated povorcitinib's durable 54-week efficacy and a favorable safety profile in moderate to severe HS, including patients previously on anti-TNF therapy. HS, a chronic, recurrent ...
An in-depth look at the immigration, environment, economy and foreign policies of the Trump administration, from the Los Angeles Times. President Trump threatened strikes on Iran energy sites and ...